Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FDA 'No Objection' ruling on new product

21 Jul 2010 07:00

RNS Number : 6497P
PureCircle Limited
21 July 2010
 



PureCircle receives FDA GRAS "No Objection" for new SG95 stevia product

 

PureCircle (LSE: PURE), the world's leading producer of high purity stevia products, is pleased to announce that the US Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle's SG95 product as a Food and Beverage ingredient in the USA. This will enable PureCircle to offer a wider and more flexible array of stevia solutions, helping to further accelerate stevia adoption in the important USA market.

 

PureCircle's high purity SG95 product is a further example of the company's leadership in innovation. Along with seven previously approved steviol glycosides, SG95 includes two new steviol gylcosides, Rebaudioside D and Rebaudioside F, both of which are receiving GRAS No Objection for the first time. The new high purity sweetener delivers great taste and consistency as well as pricing well below sugar. The product is ideally suited for applications formulated with both sugar and SG95 to achieve a low cost solution to partial sugar and calorie reduction and provide further incentive to application development. Together with PureCircle's successful high purity Reb A 97, SG95 will provide customers with an expanded range of options to improve products across their portfolios. With GRAS affirmation, PureCircle is prepared for immediate commercialisation of SG95.

 

Magomet Malsagov, CEO and Managing Director of PureCircle, said: "The launch of SG95 is a very exciting development for PureCircle in the United States with considerable future potential in global markets. Expanded use of sweet glycosides from the stevia plant in a highly consistent blend provides both formulation and economic benefits to our customers. Our Reb A 97 continues to play a major role in our portfolio particularly as our investments yield continued efficiencies that will be shared with our customers. Now SG95 will provide an additional compelling product in many applications. We are proud to continue to be at the forefront of innovation to help mainstream a better sweet choice for consumers. "

 

For more information:

PureCircle Limited (www.purecircle.com)

Jason Hecker, Group Marketing Director

(847) 630-0374

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO 

+44 7974 005 163 

Westport Communications

+44 20 7065 2690

Alan Frame

alan@westportcomms.com

Jeanette Bishop

RFC Corporate Finance Ltd

+61 8 9480 2500 

Stephen Allen

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REAPGURPMUPUGQU
Date   Source Headline
20th Sep 20167:00 amRNSFinal Results
12th Aug 20167:00 amRNSNotice of Results
29th Jul 201611:57 amRNSTotal Voting Rights
14th Jul 201611:10 amRNSDirector/PDMR Shareholding
14th Jul 201611:10 amRNSDirector/PDMR Shareholding
14th Jul 201611:09 amRNSDirector/PDMR Shareholding
14th Jul 201611:08 amRNSDirector/PDMR Shareholding
14th Jul 201611:08 amRNSDirector/PDMR Shareholding
13th Jul 20163:56 pmRNSDirector/PDMR Shareholding
12th Jul 20167:00 amRNSResignation of Chief Operating Officer
8th Jul 20167:00 amRNSAdditional Listing
6th Jul 20167:00 amRNSTrading Update and Board of Director Changes
29th Jun 20167:00 amRNSUS Customs and Border Protection Update
27th Jun 20167:57 amRNSCompany Secretary Change
2nd Jun 20168:25 amRNSU.S Customs and Border Protection Communication
23rd May 201610:42 amRNSDirector/PDMR Shareholding
29th Apr 20168:55 amRNSTotal Voting Rights
18th Apr 201610:13 amRNSDirector/PDMR Shareholding
15th Apr 20167:00 amRNSChange of Brokers
5th Apr 20167:00 amRNSTrading Statement
4th Apr 20167:00 amRNSDirectorate Change
31st Mar 20169:01 amRNSTotal Voting Rights
21st Mar 20169:07 amRNSDirector/PDMR Shareholding
14th Mar 20168:36 amRNSDirector/PDMR Shareholding
10th Mar 201610:47 amRNSDirector/PDMR Shareholding
4th Mar 20167:00 amRNSDirector/PDMR Shareholding
1st Mar 20167:00 amRNSHalf Yearly Report
18th Feb 20167:00 amRNSRecruitment of New Chief Financial Officer
17th Feb 20169:33 amRNSNotice of Results
4th Feb 20168:23 amRNSHolding(s) in Company
20th Jan 20167:00 amRNSAppointment of PWC London as auditor
6th Jan 20167:00 amRNSTrading Statement
23rd Dec 20159:22 amRNSDirector/PDMR Shareholding
18th Dec 20157:00 amRNSReb M Approval Milestone Achieved In Europe
14th Dec 20157:00 amRNSPureCircle Launches Zeta Family of New Ingredients
2nd Dec 20159:17 amRNSResult of AGM
2nd Dec 20157:55 amRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSApproval of High Purity Stevia in India
20th Nov 20158:33 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSNotice of AGM
28th Oct 20157:00 amRNSFirst Day of Dealings on Main Market
22nd Oct 20151:17 pmRNSPublication of Prospectus and Listing Update
19th Oct 201511:10 amRNSResult of Special General Meeting
16th Oct 20157:00 amRNSExercise of Options
12th Oct 20157:00 amRNSPureCircle to be Granted Patent
29th Sep 20157:01 amRNSExercise of options
21st Sep 20157:00 amRNS2015 Results& Intention to list on LSE Main Market
15th Sep 201511:33 amRNSFY15 Results Announcement and Capital Markets Day
10th Jul 20157:00 amRNSBoard Changes
7th Jul 20157:00 amRNSLTIP Update - Options Lapse, Grant and Exercise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.